China's 2024 hypertension guideline keeps the 140/90 mmHg diagnosis threshold and a below-130/80 mmHg treatment target when tolerated. It adds grading/staging/phenotyping, lifestyle and device-based therapies, and broader comorbidity coverage.
“China Hypertension Guideline 2024: What Patients Should Know” is part of iMedCompanion’s plain-language library for international patients travelling to China for care. It explains what usually happens, what to prepare, and where to find related specialists and hospitals.
No. It explains what usually happens so you can ask better questions; decisions are made with your own specialist.
The guides are published in English; interpretation and translation are arranged as a separate service.
Each guide links to related specialists and hospitals, or you can send an enquiry and a medical advisor will match you.
This 2024 Chinese consensus calls for team-based control of diabetes, obesity, lipids, and blood pressure to protect the heart, brain, and…
Cerebral amyloid angiopathy (CAA) is an age-related small-vessel disease and the leading cause of spontaneous lobar brain hemorrhage in…
Evidence-based, non-drug approaches for chronic low back pain, neck pain, osteoarthritis, tension headache and fibromyalgia — what to try…
